LIDE provides a one-stop solution with various immune-oncology platforms to support an all-around biologics R&D in immunotherapy.
> huPBMC reconstitution > huPBMC/cancer co-inoculation
> Murine Syngeneic > Humanized Syngeneic
|Mφ involved assay||In vitro assay using fresh samples from patients|
|DCs involved assay||CAR-T in vivo assay|
|NK cells involved assay||Oncolytic virus in vivo/in vitro assay|